Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation
- 30 September 2009
- journal article
- research article
- Published by Elsevier in Resuscitation
- Vol. 80 (9) , 994-999
- https://doi.org/10.1016/j.resuscitation.2009.06.007
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Serum Neuron Specific Enolase and Malondialdehyde in Patients After Out-Of-Hospital Cardiac ArrestCellular and Molecular Neurobiology, 2009
- Prediction of short-term and long-term outcomes after cardiac arrest: A prospective multivariate approach combining biochemical, clinical, electrophysiological, and neuropsychological investigations*Critical Care Medicine, 2007
- Total antioxidant capacity and superoxide dismutase activity levels in serum and gingival crevicular fluid in post‐menopausal women with chronic periodontitisJournal of Clinical Periodontology, 2006
- Ability of neuron-specific enolase to predict survival to hospital discharge after successful cardiopulmonary resuscitationCJEM, 2006
- Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma ScaleResuscitation, 2005
- Regulated hypothermia reduces brain oxidative stress after hypoxic-ischemiaBrain Research, 2004
- Serum Neuron-Specific Enolase and S-100B Protein in Cardiac Arrest Patients Treated With HypothermiaStroke, 2003
- Preconditioning and the oxidants of sudden deathCurrent Opinion in Critical Care, 2003
- Early cellular brain damage and systemic inflammatory response after cardiopulmonary resuscitation or isolated severe head trauma: a comparative pilot study on common pathomechanismsResuscitation, 2001
- In-Hospital Cardiopulmonary Resuscitation Survival in 1 Hospital and Literature ReviewMedicine, 1995